Phase II/III Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster.

NCT05710783 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

4065

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2 Infection

Interventions

BIOLOGICAL: AVX-COVID/12
BIOLOGICAL: ChAdOx-1-S[recombinant]

Sponsor

Laboratorio Avi-Mex, S.A. de C.V.

Collaborators

[object Object]
[object Object]